Skip to main content

Howard McLeod, Geoffrey Harris

Cancer Genetics has added Howard McLeod and Geoffrey Harris to its board of directors.

McLeod is the medical director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He joined Moffitt last year from the University of North Carolina's Institute for Pharmacogenomics and Individualized Therapy, of which he was the founding director.

Harris is a portfolio manager and managing partner at c7 Advisors, a healthcare advisory firm. Before c7 Advisors, Harris was managing director and co-head of the Cantor Fitzgerald Healthcare Investment Group from 2011 to 2014.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.